Does mass drug administration with azithromycin for trachoma control have an impact on the prevalence and macrolide resistance of genital Mycoplasma genitalium infection?

MHarrison; MMarks; EMHarding-Esch; MJPond; RButcher; ASolomon; NKTan; AVNori; HKako; DCMabey; +1 more... STSadiq; (2017) Does mass drug administration with azithromycin for trachoma control have an impact on the prevalence and macrolide resistance of genital Mycoplasma genitalium infection? [Conference or Workshop Item] 10.1136/sextrans-2017-053264.329

Copy

Item Type	Conference or Workshop Item (UNSPECIFIED)

Atom

BibTeX

OpenURL ContextObject in Span

Multiline CSV

OpenURL ContextObject

Dublin Core

MPEG-21 DIDL

EndNote

HTML Citation

JSON

MARC (ASCII)

MARC (ISO 2709)

METS

MODS

RDF+N3

RDF+N-Triples

RDF+XML

RIOXX2 XML

Reference Manager

Refer

Simple Metadata

ASCII Citation

EP3 XML

Export

Downloads

Full text not available from this repository.

Does mass drug administration with azithromycin for trachoma control have an impact on the prevalence and macrolide resistance of genital Mycoplasma genitalium infection?

Explore Further